In 2006, the company started an iodine recycling program for imaging departments that had leftover contrast that would go to waste at the end of the day if left unused. That program expanded into the U.S. and Canada in 2021.

The new-look device, still under development, is designed to be worn for weeks at a time. 

Their financial results are in stark opposition to several dismal reports about hospitals’ operating environments.

Big Tech’s recent expansions into medical imaging have business watchers scrambling to decipher the unspoken stratagems beneath the conspicuous moves.

The Impella RP System is still associated with significant benefits, the FDA said, but there are certain high-risk patients who should no longer be eligible for treatment.

The study, which was published in Brain and Behavior, found that individuals who used their smartphone excessively displayed different strengths in the prefrontal and parietal neural network.

Jorge Soto, MD, chair of the RSNA Annual Meeting Program Planning Committee, chief of radiology, Boston Medical Center, offers an overview of the trends, hot topics, research and technology at the Radiological Society of North America (RSNA) 2022 meeting.

More than half of surveyed radiologists worry about MRI contrast availability, yet almost all—99%—wish for contrast agents that would cut current gadolinium concentrations at least in half.

Researchers cannot yet determine whether these changes will progress or resolve in the long term.

Integra LifeSciences Holding Corporation, a global medical technology company, has agreed to acquire Surgical Innovation Associates (SIA), which is known as the manufacturer of monofilament mesh for plastic and reconstructive surgery. The deal is valued up to $140 million.